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ABSTRACT
The thyroid hormone receptors (TRs) are transcription factors which activate or
repress target genes in response to thyroid hormone. TR is synthesized in the cytoplasm,
but must shuttle to the nucleus to assert its functions. Other nuclear receptors in this
same superfamily have been shown to utilize some element of the cytoskeleton for
directed transport from the cytoplasm to the nucleus, the site of action. Using
mammalian cell transient transfection assays, the role of the cytoskeleton in subcellular
trafficking o f GFP-tagged (green fluorescent protein-tagged) TR and variants was
investigated. Experiments presented in this thesis demonstrate for the first time a possible
interaction between TR and the microtubules. This association was suggested by changes
in receptor distributions upon disruption of the cytoskeleton through in situ fractionation
or disrupting agents. Most strikingly, heterokaryon shuttling experiments show a
dependence on microtubules for efficient shuttling of the receptor between the cytoplasm
and the nucleus. Taken together these results suggest a requirement for intact
microtubules for TR to traverse the expanse of the cytoplasm. This research helps to
paint a more clear picture o f the mechanism for nucleocytoplasmic shuttling o f TR.
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INTRODUCTION

The thyroid hormone receptor (TR) is a nuclear receptor for the thyroid
hormone and acts as a transcription factor to activate or repress many genes. The
pathway o f thyroid hormone (T3) from its synthesis in the thyroid gland to its
interaction with TR in target cells plays important roles in the regulation o f growth
and development. One aspect o f regulation o f TR is its shuttling between the
cytoplasm and the nucleus. Since TR is a transcription factor, it must enter the
nucleus and bind to target DNA to affect transcription of T3 responsive genes. The
means by which other nuclear receptors and transcription factors arrive at the nucleus
has been investigated. Intriguing evidence suggests that elements of the cytoskeleton
may be important for these proteins to traverse the expanse of the cytoplasm. This
thesis research focuses on the mechanism by which TR travels through the cytoplasm
to arrive at the nucleus. The following sections review the thyroid hormone
receptors, their interaction with DNA, nucleocytoplasmic shuttling, and how elements
of the cytoskeleton contribute to cytoplasmic travel of other proteins.

THYROID HORMONE
The thyroid hormones are important hormones in all vertebrates. Through
interaction with its receptors, it regulates amphibian metamorphosis and mammalian
reproduction, growth, development, neurodevelopment, and metabolism (Forrest et
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al, 2002; Schreiber et al, 2001). The mechanisms by which the thyroid hormone acts
are specific to the species, tissues, and developmental phase involved.
In general, thyrotropin-releasing hormone (TRH) is secreted by the
hypothalamus, which in turn stimulates secretion of thyroid stimulating hormone
(TSH) by the anterior pituitary (Conn & Melmed, 1997) (FIGURE 1).
Approximately 10% o f cells in the anterior pituitary are thyrotrophs, or TSHsecreting cells (Brook and Marshall, 2001). TSH secretion also follows a circadian
rhythm, with maximum secretion near midnight, and minimum secretions at late
afternoon (Conn & Melmed, 1997). TSH then induces the thyroid gland to secrete
the thyroid hormones, thyroxin (T4) and triiodothyronine (T3) into circulation.
Thyroid hormone molecules are derived from modified tyrosine residues, in
which iodine molecules have been attached (Brook and Marshall, 2001). This
process is completely dependent on the supply o f iodine to the gland to make
hormone. Due to this dependence, the thyroid gland maintains a store o f synthesized
hormone within its follicles that may help to dampen the effects of changes in dietary
iodine uptake. T3 has a half-life of approximately 1-3 days, while the half-life of T4
is approximately 5-7 days.
Most thyroid hormone is bound to serum proteins while in circulation, and
only a very small amount o f hormone is in a “free” form (Brook and Marshall, 2001).
It is only the “free” form o f hormone that most cells respond to, and therefore much
o f the biologically active “free” T3 required for cellular activity is produced at the
target tissue through local deiodination of T4. Because the thyroid hormone is lipid
soluble, it can then pass freely through the cell membrane and into target cells,
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Figure 1. Thyroid Hormone Pathway. The hypothalamus releases TRH, which
then stimulates the pituitary to release TSH. TSH binds to receptors on the thyroid
gland, resulting in release o f thyroid hormone. The thyroid hormone then inhibits
further release o f TRH and TSH through a negative feedback loop.

although it is believed that some cells may have a membrane transport mechanism
specifically for the purpose o f free thyroid hormone intake. One study found that a
specific plasma membrane transport mechanism, system L, was important for T3
entry into the cytoplasm (Ritchie et al., 2003). It is inside target cells where the T3
interacts with TR. TSH and TRH are regulated by a negative feedback loop by the
circulating thyroid hormone.

THYROID HORMONE RECEPTOR
There are two main forms of thyroid hormone receptors, TRa and TR(3
(c-ErbA-1 and c-ErbA-2, respectively), which are encoded by two different genes. In
humans the genes for TR a and TR|3 are on chromosomes 17 and 3, respectively
(Laudet et al., 2002). TRa encodes the isoforms TR al and TRa2 which arise
through alternative splicing. TRa2 cannot bind hormone but can still bind to DNA.
It therefore may block elements of the DNA where T R al induces gene expression,
hence acting as a dominant negative inhibitor of T R a l. There are also two isoforms
of TR)3 called TRp 1 and TRP2 which also arise through alternative splicing creating
receptors which are the same in size, but differ in the tissues which express them.
The various forms of the thyroid hormone receptors carry some functional
redundancy, although they do exert functions specific to a particular isoform and are
sometimes expressed in different tissues at different stages in development (Gauthier
et al., 1999).
The thyroid hormone receptor is a ligand-modulated transcription factor, and a
member of the nuclear receptor superfamily. This superfamily includes receptors for
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retinoids, Vitamin D, and steroid hormones. TR specifically is classified as a Type II
receptor, due to its ability to bind DNA with or without ligand (Tsai and OMalley,
1994).
All receptors in this superfamily have very similar structures. There are three
main domains o f TR (Conn & Melmed, 1997; Nelson et al., 1993) (FIGURE 2). The
central domain is the DNA binding domain which is the most conserved domain
within members o f this receptor family. The DNA binding domain contains two zinc
fingers o f Cysteine-4 type. These zinc fingers interact with the major groove o f DNA
to stabilize the interaction (Brook and Marshall, 2001). It appears that the segment
near the end o f the first zinc finger, called the P box, is important for DNA binding
specificity in most receptors in this superfamily (Laudet et al., 2002; Brook and
Marshall, 2001). This area results in base pair recognition resulting in hydrogen
bonds formed with DNA in the major groove. The second zinc finger associates with
DNA via phosphate contacts. A portion at the beginning of the second zinc finger,
called the D box, plays some role in this interaction. Portions of the DNA binding
domain also play a role in dimerization.
There is an area between the DNA binding domain and the hormone binding
domain that acts as a hinge and allows bending of the receptor (Laudet et al., 2002).
The carboxyl terminal domain is responsible for ligand binding. This domain is a
hydrophobic pocket, and when bound, the hormone is closed in by a “lid” and hidden
inside the structure o f the receptor (Laudet et al., 2002; Brook and Marshall, 2001).
This ligand binding domain is also involved in dimerization, transactivation, and
nuclear localization (Ribeiro et al., 2001). The N-terminal domain plays a role in
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Figure 2. Thyroid Hormone Receptor Domains. The activation domain (AD) is at
the N-Terminus and plays a role in transcriptional activation. The DNA binding
domain (DBD) contains two zinc fingers for interaction with DNA. The Ligand
Binding domain (LBD) primarily serves to bind thyroid hormone.

transcriptional activation, and is not strongly conserved among members of the
nuclear receptor superfamily.

DNA Binding
TR binds to DNA elements within the promoter or enhancer regions near
target genes, called thyroid hormone response elements (TREs). TREs are six base
pair sequences arranged as direct repeats, inverted repeats, or palindromes. The
idealized hexameric sequence for TREs is generally 5’-AGGTCA (Conn & Melmed,
1997; Forman et al., 1992; Nelson et al., 1993). A certain degree of regulation comes
from the orientation and spacing between these hexameric sequences, and TREs seem
more variable in sequence and spacing than other hormone response elements.
Certain TREs are more selective for monomers, homodimers, or specific
heterodimers. TR a can bind to DNA as a monomer, or as a homodimer or
heterodimer with the retinoid X receptor (RXR). TRp can bind to DNA only in the
homodimer or heterodimer forms (Laudet et al., 2002). Direct repeats spaced by 4
base pairs tend to bind TR/RXR heterodimers strongly, while inverted palindromes
with 6 base pair spacing also bind homodimers (Ribeiro et al., 2001). In general, the
TR/RXR heterodimer binds DNA with a higher affinity than the monomer or
homodimer form. When T3 is present, it is predominantly the heterodimers that tend
to stay associated with DNA.

9

Coactivalors and Corepressors
TREs can be positive (pTRE) or negative (nTRE). The most understood and
probably most abundant o f the two is the pTRE. In this situation, unliganded TR
(called the apo-form) generally represses transcription of target genes, whereas the
ligand bound form (holo-form) causes activation of target genes (Laudet et al., 2002).
The opposite is true for a nTRE where activation occurs in the absence o f thyroid
hormone, and repression occurs when ligand is bound.
In the situation of a pTRE, unliganded TRs have been shown to inhibit the
assembly o f the transcriptional preinitiation complex (PIC) which forms at the
promotor of a pTRE to facilitate transcription (Tong et al., 1995; Tong et al., 1996;
Baniahmed et al., 1993; Fondell et al., 1996).

The C terminal region of both T R a

and TRp have been shown to interact with many elements of the PIC including
TATA-binding protein (TBP) and transcription factor IIB (TFIIB) alone, as well as
TFIIB-TBP, TFIIA-TBP, and TFIIB-TFIIA-TBP complexes. It is believed that this
interaction blocks the PIC from properly forming and initiating transcription from a
TRE. When the thyroid hormone binds to the ligand binding domain of TR, this
association is broken and the PIC can assemble unimpeded to activate transcription.
It is becoming increasingly clear that in addition to these interactions, TR
must have help from corepressors and coactivators to effectively repress and activate
target genes at a pTRE. Various corepressors such as N-CoR (nuclear receptor
corepressor) and SMRT (silencing mediator for retinoid and thyroid hormone
receptors) have been shown to interact with unliganded TR or with TR-RXR
heterodimers. These corepressors inhibit transcriptional activation by recruiting
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histone deacetylases such as HDAC1 (Nagy et al., 1997). The histone deacetylase
functions to make the DNA at the site o f the target gene inaccessible through altering
chromatin structure into a less open conformation. Upon thyroid hormone binding to
TR, the corepressors dissociate from TR, and coactivators such as p300 can then bind
to TR or TR-RXR. P300 possesses histone acetyltransferase activity (HAT), which
may help to open up chromatin at the target gene to allow transcription to proceed
(Ogryzko et al., 1996; Li et al., 1999). In fact, it has been shown that the HAT
function o f p300 is required for its ability to activate transcription through liganded
TR-RXR heterocomplexes (Li et al., 2000). It has also been suggested that TR
homodimers interact with corepressors such as SMRT to a higher degree than TRRXR heterodimers, thus acting to repress transcription of target genes (Yoh and
Privalsky, 2001). An additional level of regulation would arise from the TRE itself,
as some TREs bind to homodimers or heterodimers more efficiently.
An opposite situation occurs at a negative TRE, where unliganded TR
activates transcription, and TR with ligand bound represses transcription of target
genes. The mechanism by which transactivation occurs at a nTRE is more poorly
understood than that of a pTRE.

Interestingly, in the absence of bound ligand,

corepressors such as SMRT and N-CoR are still bound to the receptors at nTREs. It
has been shown that mutating TR in a way to inhibit binding o f SMRT and N-CoR
leads to inhibition o f transcriptional activation at nTREs (Berghagan et al., 2002).
Using protease digestion combined with mobility shift assays, it has been
demonstrated that TR -SM R T complexes have different conformations at nTREs than
at pTREs. It is possible that the alternate conformation assumed by TR-SM RT at a

nTRE results in recruitment of a different set o f proteins that then leads to
transcriptional activation instead o f repression.
There are many target genes o f TR which possess TREs, including the genes
for glycerol phosphate dehydrogenase, a-myosin heavy chain expression in cardiac
muscle, TSH production, prestin protein, and sarcoplasmic reticulum CaATPase
(Conn & Melmed, 1997; Brook and Marshall, 2001; Weber et al., 2002; Gauthier et
al., 1999).

G121A: M utant Form o fT R
In addition to the normal forms of TRa and TR|3, many mutant forms of TRs
exist. v-erbA is a naturally occurring highly mutated homolog of TRa that is an
oncogene carried by the avian erythroblastosis virus (AEV) (Laudet and Gronemeyer,
2002.). There are also many mutated forms of the receptors in humans that lead to
disease states, including generalized thyroid hormone resistance (Behr and Loos,
1992).
In addition to these naturally occurring homologs and forms of TR, other
mutant forms of human TRp have been created through site-directed mutagenesis in
the laboratory (Nelson et al., 1993). One of these mutant forms, G121A, has an
alanine substituted for a glycine at TRp amino acid position 121 (FIGURE 3). This
substitution falls in the first DNA binding zinc finger o f the DNA binding domain of
TR, more specifically in the P box. An alanine was used in order to minimize the
effect o f the substitution on the a-helical structure o f the DNA binding domain of TR.

12

V
K

T

D
I
V
C
K
G
Y

Q

c

V

K
C

G 121

R
N

\

Q
E

R
TLDKDE

( G)FFRRTIQKNLHPSY
130

FKKCIYVGMA
170

Figure 3. Zinc finger region o f TRa. The DNA binding zinc finger domain of T R a
contains two cysteine 4 type zinc fingers. The P box amino acids are circled, and the
D box amino acids are boxed. The mutation in G 121A is at the glycine at position
121 which in G121A is substituted by an alanine (Nelson et al., 1993).

Despite the substitution in the P box of the DNA binding domain, G121A can
still bind DNA and can bind ligand, but it cannot transactivate target genes (Nelson et
al., 1993). DNA binding was shown through gel shift assays with four different
TREs to assess binding affinity. In only one case did G121A bind with any reduced
affinity to the TRE. Activation o f genes was assessed by cotransfection of COS
(African green monkey kidney ) cells with G121A and TRE-linked CAT
(cloramphenicol acetyl transferase) reporter plasmids.

The inability o f G121A to

transactivate target genes suggests that this amino acid in the P box of TR plays some
role in interaction with coactivators or corepressors important for transactivation.
Active transcription factors generally associate with the nuclear matrix, the
fibrilogranular structure o f the nucleus (Berezney and Jeon, 1995). T R a has been
shown to associate with the nuclear matrix (Nicoll et al., 2003; Hollingshead, 2001).
Since G121A is a transactivation mutant, it would not be expected to associate with
the nuclear matrix. Therefore, G121A has a much more cytoplasmic distribution than
normal TR, which has been shown in localization studies of G121A (Hollinghead,
2001). This makes G121A particularly useful for studying cytoplasmic factors that
affect normal TR. Another mutant form of TR, v-Erb A, has also been shown to have
a more cytoplasmic localization than normal TR (Bunn et al. 2001). Given the
cytoplasmic localization of mutant TRs, it is possible that mutant forms of the
receptor such as G121A remain in locations within the cell, such as associated with
the cytoskeleton in the cytoplasm, that the normal receptor passes through transiently
on its way to the nucleus.
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NUCLEOCYTOPLASMIC SHUTTLING OF TR

Nuclear Import o f TR
Nuclear pore complexes (NPCs), are structures embedded in the nuclear
envelope that act as a gateway for ions and molecules passing between the cytoplasm
and the nucleus o f a cell. NPCs are composed primarily of multiple copies of
proteins called nucleoporins, which arrange to create an octagonal symmetry o f the
NPC including eight internal spokes (Rout et al., 2000; Gorlich and Kutay, 1999;
Rout and Aitchison, 2001). Within the structure is a central channel which serves as
the actual transporter. Filaments create a basket-like structure on the nuclear side of
the complex, while filaments on the cytoplasmic side of the NPC spread in many
directions. Nucleoporins which make up the NPC are characterized by the presence
o f phenylalanine-glycine (FG) repeats (Rout and Aitchison, 2001; Ribbick and
Gorlich, 2002;Ben-Efraim and Gerace, 2001). It is believed that these repeats are
essential for facilitated transport to proceed, although the exact mechanism of passage
through the central channel is still a matter of debate.
Three main models currently exist to explain the role of the FG repeats, and
the actual process o f translocation through the NPC. Ions and molecules o f 20-40
kDa can traverse the NPC by way o f passive diffusion in theory, although most
proteins enter by a facilitated pathway. Larger molecules must traverse the NPC by
means o f a facilitated transport pathway (Ribbick and Gorlich, 2002). Facilitated
transport is mediated by several factors, the small GTPase Ran, RanGEF and
RanGAP. RanGEF is found in high concentration in the nucleus, and RanGAP is
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found in high concentration on the cytoplasmic side of the NPC (Gorlich and Kutay,
1999). Ran shuttles between the nucleus and the cytoplasm, and a gradient of forms
of Ran exist between the two compartments. While on the cytoplasmic side o f the
nuclear membrane, Ran is found predominantly with GDP bound, and while on the
nuclear side, is found with GTP bound. The conformation of Ran changes depending
on which form it is in, allowing for Ran to interact with different effector proteins.
In the cytoplasm, cargo proteins which contain nuclear localization sequences
(NLSs) bind to import proteins (importins), usually as a complex of importin a and
importin (3 (FIGURE 4). This complex enters the nucleus through the NPC (Gorlich
and Kutay, 1999; Kaffman and O ’Shea, 1999). Once in the nucleus, RanGTP binds
to the import complex and causes it to release its cargo. The importin a / importin (3 /
RanGTP complex is then exported to the cytoplasm. In the cytoplasm, RanGAP
removes the RanGTP from the importin complex, so that the importin can bind and
carry new cargo into the nucleus. Hydrolysis of GTP occurs, thus maintaining the
concentration gradient of RanGTP and RanGDP between the nucleus and cytoplasm.
Nuclear export utilizes a pathway involving similar mechanisms. For nuclear
export, cargo has a nuclear export sequence which is recognized by an export protein
(exportin). The cargo and exportin form a complex with RanGTP, which passes out
o f the nucleus through the NPC. In the cytoplasm, RanGAP causes the complex to
dissociate, and exportin can re-enter the nucleus through the NPC.
Hydrolysis of GTP is not required for translocation of cargo through the NPC,
dissociation o f the cargo from the import complex, or export of the importin. GTP
hydrolysis has been shown only to be necessary for maintaining the gradient of
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Figure 4. Nuclear Import Process. In the cytoplasm importins (I) attach to
cargo (C) containing a nuclear localization sequence, and the complex enters the
nucleus through the NPC. RanGTP binds to the complex in the nucleus releasing
cargo. RanGTP/importin complex exits the nucleus, where RanGAP causes
release o f RanGTP and conversion to RanGDP.
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RanGTP and RanGDP across the nuclear membrane, thus allowing the importins and
exportins to operate over and over again (Ribbeck et al, 1999).
The exact mechanism that TR utilizes to traverse the NPC is a current area of
investigation in our laboratory (Bunn et al., 2001; Nicoll et al., 2003). Little research
has been performed, however, on how TR reaches the NPC on the cytoplasmic side.
TR could simply diffuse through the cytoplasm until it reaches the NPC, or there
could be a mechanism that allows TR to take a more direct track towards the NPC,
possibly via some element o f the cytoskeleton.

Cytoskeleton and Protein Movement
The cytoskeleton is made up o f protein fibers that perform functions in the
cell such as motility, chromosome movement, establishing cell shape, and
intracellular transport o f organelles and proteins. The three main filaments of the
cytoskeleton are actin filaments (microfilaments), intermediate filaments, and
microtubules (Lodish et ah, 1995).
Actin filaments are the thinnest filaments at approximately 8 nm in diameter
(Lodish et al., 1995). They specifically serve functions in mitosis, cytokinesis, cell
locomotion, and interact with myosin in muscle contraction. There are two main
forms o f actin, F (filamentous) actin and G (globular) actin. G actin is a monomer,
and these monomers polymerize to form F actin. Each actin molecule is complexed
with a Mg2+ cation and with ATP or ADP. ATP hydrolysis leads to assembly of F
actin.

Filamentous actin is a long flexible filament in which all actin monomers are
arranged with the same polarity. The two ends of an actin filament are referred to as
the pointed (-) and barbed (+) ends. Actin filaments elongate more rapidly at the (+)
end than the (-) end, although elongation does occur at both ends. Bundles o f actin
filaments, called stress fibers, run the length of the cell and are usually visible with
light microscopy. The rest o f the actin network is too small to be visualized with the
light microscope.
Myosin is the main motor protein for actin. There are three main domains of
a myosin protein, the head, neck, and tail regions (Lodish et al., 1995). The head
region binds to actin and to ATP, the tail region contains various other binding sites,
and the neck connects the head and tail regions and provides regulatory functions to
affect binding o f the head. The head region of myosin binds to actin and slides or
walks along the filament.
The most characterized role of myosin is in muscle contraction. Additionally,
myosins are thought to associate and disassociate rather quickly from actin filaments,
and therefore be ill suited for cargo transport. Recently, however, some forms of
myosin, specifically M yosin V and myosin IXb, have been shown to be processive
motor proteins which could transport cargo directionally within the cell (Sakamoto et
al., 2000; Inoue et al., 2002). Myosin V, a two-headed myosin, was shown to be a
processive motor that moves cargo towards the barbed (+) end o f actin, and seems to
stay associated with the filaments throughout the duration of the transport process
(Sakamoto et al., 2000). Myosin IXb is a single headed myosin, and was shown to be

a minus-end directed processive motor protein, which also stays associated with the
filaments for a long duration (Inoue et al., 2002).
Intermediate filaments (IF) are 10 nm in diameter and consist o f five types of
proteins (Lodish et al., 1995). These IF protein subunits are a-helix rods which then
combine to make larger fibers. Their assembly is not dependent on GTP or ATP.
They are more stable than actin and microtubules, and play a more structural role in
the cell in supporting cell and nuclear shape, and anchoring muscle cell filaments.
They attach to the cellular and nuclear membranes to help provide structural rigidity.
They do not seem to be essential for any types o f movement within the cell, and
motor proteins that associate with intermediate filaments have not been found. It is
thought that intermediate filaments associate closely with the microtubule
cytoskeleton, and the two networks sometimes have very similar distributions in the
cell.
Microtubules are the largest cytoskeletal filaments at 24 nm in diameter, and
are hollow cylinders (Lodish et al., 1995). They are composed of heterodimers
containing one a-tubulin and one (3-tubulin monomer. The heterodimers arrange
head to tail to produce protofilaments, which then assemble into a tubelike structure.
Each monomer binds one GTP molecule, but only the (3-tubulin GTP is hydrolyzable.
The microtubules are elongated and disassembled by addition or removal o f dimers of
a and p tubulin, which is powered by GTP hydrolysis. At one end of a microtubule
are only a-tubulin subunits, and at the other only p subunits. This arrangement
produces a polarity, which is referred to by (+) and (-) ends. Assembly proceeds
more quickly at the (+) end than the (-) end. Microtubules also radiate from specific
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sites o f organization, called Microtuble Organizing Centers, or MTOCs (Lodish et al.,
1995). There are usually two MTOCs located near the nucleus. The assembly of
microtubules originates at these centers, with the (-) ends at the MTOC and the (+)
ends near the membrane of the cell.
Microtubules make up cilia and flagella, align chromosomes during meiosis
and mitosis, and are also involved in intracellular movement (Lodish et al., 1995).
One group o f microtubule associated proteins (MAPs) serve as ATP-dependent
motors to move along microtubules and transport vesicles, organelles, and proteins.
Kinesin and dynein are two such motor MAPs that can move cargo directionally
within the cell. Kinesin is usually a (+) end directed motor protein, delivering cargo
near the periphery o f the cell, and dynein is a (-) end directed motor protein,
delivering cargo near the nucleus.

Cytoskeletal Dynamics
It is believed that cytoskeletal filaments work in concert as a network with
constant communication and interaction to influence various aspects of cell
movement, cell shape, and intracellular transport (Gavin, 1997). In addition to the
overlapping distributions o f microtubules and intermediate filaments, it appears that
actin filaments and microtubules specifically interact in some manner as well (Yarm
et al., 2001). It may be that there is a direct interaction through linker proteins, or it
may just be that the two filament systems affect one another indirectly. There have
been various putative linker proteins identified, although the scope of these
interactions remains to be seen. It has also been shown that the two filament systems
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affect one another through regulatory factors. For instance, it has been shown that
GEF-H1 (Rho guanine nucleotide exchange factor-FIl) affects actin polymerization
based on changes in the microtubule cytoskeleton (Krendel et ah, 2002).
Intracellular transport o f organelles and vesicles through the cytoplasm
utilizing some portion o f the cytoskeleton as a directed track is well characterized
(Langford, 1995). More recently, there is evidence that proteins not associated with
vesicles also can utilize this same cytoskeletal machinery for directed movement in
the cell instead o f relying on simple diffusion. Individual proteins can also use an
element o f the cytoskeleton as an anchor to maintain a cytoplasmic distribution until
some other signal is produced to allow the protein to be released and move into the
nucleus.
There are many examples of protein interactions with the cytoskeleton for the
purpose o f sequestration in the cytoplasm or for nucleocytoplasmic shuttling. A few
examples o f proteins which have been shown to have interactions for the purpose of
sequestration are IkBcx, transcription factor MIZ-1, and Arabidopsis plant protein
COP1 (Crepieux et al., 1997; Zieglebauer et al., 2001; and Matsui et al., 1995).
Examples o f proteins which have been shown to associate with the cytoskeleton for
the purpose o f nucleocytoplasmic shuttling are AE1 anion exchangers, autoimmune
regulator protein (AIRE), chemokine receptors CXCR1 and CXCR2, and tumor
suppressor p53, (Adair-Kirk et al., 2001; Pitkanen et al., 2001; Zaslaver et al., 2001;
Giannakakou et al., 2002). In addition, there are other proteins for which an
interaction with the cytoskeleton has been found which are closely related to thyroid
hormone receptors. For example, the glucocorticoid receptor (GR), the Parathyroid
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hormone related protein (PTH-rp), and the Vitamin D receptor (VDR), interact with
microtubules and seem to utilize the microtubule network for nucleocytoplasmic
movement.

Glucocorticoid Receptor
Perhaps the most characterized and relevant example of protein movement
along cytoskeletal filaments is the example of the glucocorticoid receptor (GR). GR
is a member o f the nuclear receptor superfamily along with TR, and shares many
characteristics with TR.
When hormone is absent or at low levels, GR is mostly cytoplasmic. Upon
addition o f hormone, GR rapidly enters the nucleus, and is then able to shuttle back to
the cytoplasm upon hormone withdrawal. It has been shown that this shuttling
process is dependent on an intact cytoskeleton. More specifically, it is believed that
the microtubules play a role in the directed motion o f the GR in the cytoplasm
(Galigniana et al., 1999; Galigniana et al., 2001; Galigniana et al., 1998). In
addition, experiments have shown that under physiological conditions with an intact
cytoskeleton, GR requires heat shock protein 90 (hsp90) to move from the cytoplasm
to the nucleus (Galigniana et al., 1998). Heat shock proteins are known to directly
interact with many nuclear receptors. The interaction of the heat shock protein and
the receptor changes the conformation o f the hormone binding domain o f the receptor
to increase its affinity for the hormone (Pratt and Toft, 1997).
A GR dephosphorylation event has also been shown to be a required step in
the process o f movement from the cytoplasm to the nucleus (Galigniana et al., 1999).
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GR-hsp90 heterocomplexes immunoadsorbed from cell cytosol, have been shown to
also contain dynein and the immimophilin FKBP52. FKBP52 has been shown to bind
to hsp90, GR, and dynein, and therefore may be the linker between GR-hsp90
heterocomplex and the microtubule motor protein (Galigniana et al., 2001).
This information leads to a model where cytoplasmic GR, upon addition of
hormone, translocates to the nucleus via movement through dynein on a microtubule
track. It is believed that GR can also diffuse throughout the cytoplasm until reaching
the NPC, however this mechanism appears to be secondary to the more directive
transport in intact cells (Galigniana et al., 1998).

Parathyroid Hormone Related Protein
Another example of cytoskeletal dependent nucleocytoplasmic shuttling is the
parathyroid hormone (PTH)-related protein. The N terminal domain of PTH-related
protein is very similar to the actual parathyroid hormone (PTH), and both share many
common functions and a common receptor (Lam et al., 2002). PTH-related protein
was initially discovered due to its secretion by certain types of cancers, although it
also plays roles in autocrine and paracrine functions
A green fluorescent protein (GFP)-tagged construct for PTH-related protein
overexpressed in cells was shown to colocalize with microtubules (Lam et al., 2002).
Studies using in vitro polymerized microtubules also showed association with PTHrelated protein, and this interaction was enhanced with the addition o f importin p 1.
The use o f nocodazole, a microtubule disruption drug, also inhibited
nucleocytoplasmic shuttling, as demonstrated through fluorescence recovery after
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photobleaching (FRAP) experiments. These results indicate an important function of
the microtubules in nucleocytoplasmic shuttling of PTH-related protein.

Vitamin D Receptor
It appears that the cytoskeleton plays a direct role in protein trafficking in the
case o f the Vitamin D receptor (VDR) as well. VDR is a member o f the nuclear
receptor superfamily o f transcription factors along with TR. VDR and
l,25(OH)2D3, the active form o f vitamin D, form a complex which interacts with
vitamin D Response elements within target genes. It was once thought that VDR was
only localized to the nucleus, but studies using fluorescent-tagged ligand to track
VDR in living cultured cells, showed that VDR also localizes to the cytoplasm,
specifically to ER, Golgi complexes, and microtubules (Barsony et al., 1997).
In light o f the fact that VDR associates with microtubules, their role in import
o f VDR from the cytoplasm to nucleus was investigated (Kamimura et al., 1995).
Using human monocytes and microtubule disrupting agents,it was found that for a
normal response to vitamin D involving nuclear import of VDR, the microtubule
network was necessary after vitamin D-VDR complex formation. These experiments
showed that VDR may rely on the microtubules for nucleocytoplasmic shuttling, and
this process could have widespread effects on gene regulation.

Question addressed in thesis
The fact that other nuclear receptors utilize an element o f the cytoskeleton for
directed movement in the cell leads to the question of whether the TR utilizes a
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similar mechanism. None of the TR literature thus far addresses this issue. This is
possibly due to the more nuclear distributions of TR, which makes investigations into
cytoplasmic localizations, and hence a cytoskeletal interaction, more difficult. Using
fluorescent protein fusions o f the two main forms of TR, as well as a transactivation
mutant with a more cytoplasmic localization, this issue was investigated. GFP is a
fluorescent protein derived from the jellyfish Aequorea victoria (Tsien, 1998). GFP
along with other variants such as cyan fluorescent protein (CFP) and yellow
fluorescent protein (YFP) provide an excellent way to tag and track proteins within
live or fixed cells. The overall objective of this research was to provide insight into a
step in regulation o f TR that occurs before the receptor even enters the nucleus.
Insight into this step o f TR action will help to form an overall picture o f thyroid
hormone pathway function, and possibly a clearer picture of the mechanism of
nucleocytoplasmic shuttling in general. In this research, three main questions were
addressed.

1) Does TR colocalize with microtubules or actin filaments?
2) Does disruption of the microtubules or actin filaments affect TR localization?
3) Is shuttling o f TR dependent on microtubules or actin filaments?
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MATERIALS AND METHODS
PLASMIDS
Expression vectors for YFP fused to the N-terminus of human cytoplasmic (3actin and to human a-tubulin were purchased from Clontech.
Expression vectors for GFP-G121A and GFP-TRp were subcloned by PCR
into pEG FP-Cl (Clontech) by other members of Dr. Allison’s lab. G121A and TRp
are fused to the C terminus o f GFP. G FP-TRa was constructed as described (Bunn et
al., 2001).
All GFP and YFP plasmids contain a kanamycin resistance gene which aids in
their amplification and selection. Cloned gene constructs are under control o f a
cytomegalovirus (CMV) promoter.
All plasmids were amplified using Qiagen MIDI plasmid preparation kits.
This involved transformation o f competent E . coli D H 5a cells. First, 50 ng of
plasmid DNA diluted in 10 pi o f CaC12-Tris was added to 0.1 ml o f D H 5a cells and
incubated for 40 minutes. After the incubation, cells were heat shocked at 42°C for 2
minutes. 0.4 ml LB (Luria Bertani) was then added to the mixture, and incubated for
1 hour at 37°C (Sambrook and Russell, 2001). After the incubation, 0.1 ml of
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transformed bacteria were plated on pre-warmed LB-agar plates containing
kanamycin at 30jig/ml. The plates were then grown overnight at 37°C.
From the plated bacteria, one colony was selected and added to 3 ml LB
containing appropriate antibiotic. This starter culture was grown shaking at 37°C for
approximately 8 hours to achieve logarithmic growth phase. 1 ml of the starter
culture was then added to 100ml LB with appropriate antibiotic and grown shaking at
37°C overnight. The plasmid DNA was then purified with plasmid MIDI prep kits
according to the manufacturer’s protocol.

Subcloning o f Plasmids
The CFP-G121A plasmid was constructed by subcloning G121A cDNA into
pECFP-Cl (ClonTech Laboratories, Palo Alto, CA) as described below. Expression
of G121A fused to the C terminus of CFP is controlled by the cytomegalovirus
(CMV) promotor.
4 pg o f pECFP-Cl and GFP-G121A were cut with the restriction enzyme
E c o R l. The digest was allowed to proceed at 37°C for 3 hours. Digested DNA was
then purified with Qiagen PCR purification kits before the second digestion. DNA
was then cut with the restriction enzyme BamHl at 37°C overnight. Following the
second digestion, restriction digests were run on 1% agarose gels and stained with
ethidium bromide at 1/10000 dilution to assure proper digestion and to separate
fragments. The bands containing the pECFP vector and G121A insert were excised
from the gel and purified with QIAquick gel extraction kit according to the
m anufacturer’s protocol. Vector and insert were then ligated using 3 units T4 DNA
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ligase (Promega), overnight at 16°C . Insert:vector molar ratios o f 3:1 and 1:1 were
used. After the ligation, X L -10 Gold ultracompetant cells (Stratagene) were
transformed with the plasmid construct and spread on LB/kanamyacin plates. Single
colonies were then selected for culturing and plasmid isolation as described earlier.

CELL CULTURE
NIH Swiss Mouse embryo fibroblast (NIH-3T3) cells were cultured and
maintained in DMEM ( Dulbecco’s Modified Eagle’s Medium) (Gibco) with 10%
calf serum, supplemented with penicillin (lOOU/ml) and streptomycin (lOOpg/ml).
HeLa cells were maintained in MEM (Minimal Essential Medium) (Gibco) with 10%
Fetal Bovine Serum, supplemented with penicillin and streptomycin. All cells were
kept in a 37° C incubator at 98% humidity and 5% CCA

Transfections
Cells were seeded at approximately 0.15-0.2 x 105 cells per well in 0.5 ml
DMEM without antibiotics into 4 well chamber slides (LabTek) approximately 24
hours prior to transfection. Transient transfections were then performed by the
liposome-complex formation method. 2 pg o f plasmid DNA was mixed with 10 pi
LipofectAmine reagent (Gibco BRL) in Opti-MEM I reduced serum media (Gibco)
for a total volume o f 200 pi, and incubated at room temperature for 20 min. After the
incubation period, 200 pi of the liposome-complex mixture was combined with an
additional 100 pi Opti-MEM and 200 pi DMEM for a total volume o f 500 pi.
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Complete media was aspirated off cells, and the transfection medium was added.
Cells were incubated at 37° C for approximately 24 hours.
For cytochalasin D (Sigma) and colchicine (Sigma) experiments, prior to
fixation, transfection medium was aspirated off and replaced with DMEM alone for
no treatment controls, DMEM with the corresponding volume of DMSO for vehicle
controls, and DMEM with varying concentrations of cytochalasin D (5-15 pM) or
colchicine (30 pM) dissolved in DMSO for drug treatment groups. Cells were
returned to the incubator for 1 hour and then fixed as described under whole cell
fixations, except that the cells were not maintained on ice.

In Situ Extractions
After 24 hours incubation, media was aspirated off, and chamber slides placed
on ice. Cells were washed in ice-cold D-PBS 3 times for 15 seconds. Procedures
follow those in Cells: A Laboratory Manual (Spector et al., 1998).
W hole Cell: Following the D-PBS wash, cells were fixed with 3.7% formaldehyde
in D-PBS for 10 minutes. The cells were then washed 3 times in D-PBS for 5
minutes. Cells were then permeabilized with 0.2% Triton-X-100 in D-PBS for 5
minutes. Finally, cells were washed 3 times in D-PBS for 5 minutes each. Cells were
kept on ice for all steps until formaldehyde fixation.
Cytoskeletal Fixation: Following initial D-PBS wash, cells were washed three times
for 5 minutes each in 0.5 ml ice cold Cytoskeleton Buffer (lOmM PIPES, 0.1 M
NaCl, 3 mM M gCh, 1 mM EGTA, 300mM sucrose, 0.5% Triton-X-100, 12 mM
PMSF) with VRC (Vanadyl Ribonucleoside Complex) at 2mM. VRC is used to
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inhibit RNA degradation. Cells were then fixed for 10 minutes with 0.5 ml o f 3.7%
formaldehyde in Cytoskeleton Buffer without VRC at room temperature. After
fixation, cells were washed three times with 0.5 ml D-PBS for five minutes each. All
steps were performed on ice prior to formaldehyde fixation. This extraction
procedure should remove all soluble components in the cell, and minimally affect the
cytoskeleton.
Nuclear Matrix-Intermediate Filament Fixation: Following initial D-PBS washes,
cells were washed three times for 3-5 minutes in 0.5 ml Cytoskeleton Buffer with
VRC. Cells were then washed two times in 0.5 ml Extraction Buffer (lOmM PIPES,
3mM MgCl2, ImM EGTA, 300mM sucrose, 250mM ammonium sulfate, 12 mM
PMSF) with 2mM VRC for 3-5 minutes. Cells were then incubated in 0.5 ml
Digestion Buffer (lOmM PIPES, 50mM NaCl, 3mM MgCl2, ImM EGTA, 300mM
sucrose, 200-400units DNase per ml (Epicentre), 0.5% Triton-X-100, 12 mM PMSF,
20mM VRC) at room temperature with gentle agitation. After 30-50 minutes
incubation, cells were washed in Extraction Buffer two times for 5 minutes. Cells
were then fixed in 3.7% formaldehyde in Digestion Buffer (without DNase or VRC)
for 10 minutes at room temperature. Finally, cells were washed in 0.5 ml D-PBS two
times for 5minutes. All steps prior to formaldehyde fixation were performed on ice.
After fixation, all soluble components of the cell should be removed, including most
o f the tubulin and actin cytoskeleton. The main elements remaining are the more
stable intermediate filaments and the nuclear matrix.
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Following each extraction and fixation procedure, all slides were mounted in
Vectashield with DAPI (Vector labs). Coverslips were sealed with nail polish and
kept in the dark at 4°C until viewing with a fluorescence microscope.

HETEROKARYONS
Heterokaryon experiments were performed following a well established
method ( Spector et al., 1998). 2 ml of NIH3T3 cells were plated on sterile glass
coverslips in 6-well plates (Nunc) at approximately 1 X 105 cells per well.
Approximately 24 hours after plating, cells were transfected with G FP-TRa
expression vector using the liposome complex formation method. For each well, 2 pg
plasmid was diluted to 100 pi with Opti-MEM, and 10 pi LipofectAmine was added
to 90 pi Opti-MEM. The two solutions were then combined and left to incubate at
room temperature for 15 minutes. During this incubation, cells in the 6-well plates
were rinsed in 2 ml o f Opti-MEM. Subsequently, 800 pi Opti-MEM was added to the
liposome plasmid mixture, mixed, and added to the plated cells for 1 ml total per
well.
Approximately 16 hours after transfection, HeLa cells were added to the
mouse cells. This was done by resuspending HeLa cells in Heterokaryon Growth
Medium (70% DMEM, 10% FBS, 20% sterile ddH20 ), and plating them at a
concentration o f approximately 7 X 103 cells per well onto the NIH3T3 cells which
had been rinsed in Heterokaryon Growth Medium. 10 pi of lOmg/ml cycloheximide
(Sigma) for a final concentration o f 50 pg/ml was added to each well to prevent new
protein synthesis. The cells were then incubated for 2.5 hours at 37°C. After the
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incubation, medium was replaced with 2 ml pre-warmed D-PBS, and then repeated to
rinse the cells. Coverslips were then placed cell side down on a lOOpl drop o f pre
warmed 50% polyethylene glycol (PEG) 1500 (Roche Diagnostics) on parafilm to
allow for cell fusion. Coverslips were allowed to remain on the PEG for exactly 2
minutes. During this step, fresh D-PBS was added to each well. After the 2 minute
incubation, coverslips were returned to the 6 well plate, cell side up. After washing
15 seconds, fresh D-PBS was added to the wells. Next, the D-PBS was aspirated off,
and 2 ml Heterokaryon Growth Medium with 100 pg/ml cycloheximide was added.
In vehicle and drug treatment slides, colchicine or cytochalasin-D in DMSO, or an
equivalent volume o f DMSO alone was added to each well at this time. Cells were
then incubated for 1 hour to allow shuttling to occur.
Following the incubation, cells were fixed. This was done by rinsing cells 3
times in D-PBS for 15 seconds each wash. Cells were then fixed in 3.7%
formaldehyde for 10 minutes. Cells were then rinsed 3 times again in D-PBS for 5
minutes each wash. Cells were then permeabilized in 0.2% Triton-X-100 in D-PBS
for 5 minutes. Finally, cells were rinsed 3 times in D-PBS for 5 minutes each wash.
To stain the DNA, 1 ml or 10 jag/ml Hoechst 33258 dye in D-PBS was added to the
wells for 20 minutes in the dark. Cells were then washed 3 times in D-PBS for 15
seconds each wash. Coverslips were mounted in Vectashield and sealed with nail
polish. Slides were then stored at 4°C until viewing.

FLUORESCENCE MICROSCOPY
All slides were viewed on an Olympus Fluorescence Microscope. A FITC
filter (NB) was used to visualize GFP fluorescence, and the UV filter (NU) was used
for viewing DAPI fluorescence. Photographs were taken of selected cells using a
Cooke Sensi Cam High Performance Digital Camera. Images were stored and
pseudocolored using Iplab software for IBM and M acintosh computers.
For each experiment with NIH3T3 cells, 3 trials o f each experiment were
performed. At least 100 cells for each treatment of each trial were counted. The only
exceptions were for experiments dealing with cytoskeletal disruption, including the
Cytoskeletal and Nuclear Matrix Intermediate Filament fixations, where too many
cells had lost adhesion to substrate due to loss of the cytoskeleton, and counting 100
cells was not possible. In these cases, as many cells were counted as possible for 3
separate trials.
For G FP-TRa, GFP-TRp, and GFP-G121A experiments, cells were scored
qualitatively according to their distributions. Initially, a score of 0 through 4 was
assigned to each cell counted: 0, entirely cytoplasmic distribution; 1, distribution
throughout the cell, but with greater fluorescence in the cytoplasm; 2, even whole
cell distribution; 3, whole cell distribution with greater fluorescence in the nucleus; 4,
completely nuclear distribution. Cells were also categorized as having foci or no foci
in each category. For graphical representation and statistical analysis, cells were then
grouped according to larger categories, because some categories were irrelevant or
insignificant for the experiment at hand.
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For heterokaryon experiments, at least 20 heterokaryons were counted from
various numbers of trials. It was possible to distinguish NIH-3T3 nuclei from HeLa
nuclei due to their differential staining with the Hoescht DNA stain. NIH-3T3 nuclei
appear spotted or punctuate, while HeLa nuclei appear diffuse (Bunn et al., 2001). In
some cases where justified, such as when no shuttling was observed, homokaryons
were also counted along with heterokaryons. Heterokaryons were classified as non
shuttling, shuttling with uneven fluorescence in the nuclei, and shuttling with even
fluorescence in the nuclei.
All cells counts were performed blind, without prior knowledge o f the
treatment. The counts for each experiment type were also performed within 2 days of
one another to avoid differences in appearance of cell fluorescence due to the age of
the mercury bulb, or to slight variations in classifications into the specific categories.

STATISTICAL TESTING
Once cells were counted, results were tested for statistical significance using
SAS statistical software. A log-linear analysis with no three variable interaction was
performed on each data set. This resulted in a p value and a likelihood ratio for each
experiment. A p value o f p<0.01 was considered significant, while anything greater
than this value was not considered significant. A likelihood ratio o f greater than 0.05
indicated that results were likely due to the treatment and not due to errors related to
the various trials. Liklihood ratios were not available for a few experiments due to
the uneven numbers o f cells counted in those trials.
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RESULTS

DISRUPTION OF CYTOSKELETON EFFECTS TR LOCALIZATION
The first set o f experiments that was performed was aimed at determining if
disruption of the cytoskeleton had an effect on the subcellular distribution of TR. If
disruption of the cytoskeleton did effect receptor localization, this could indicate an
association between an element o f the cytoskeleton and the receptor. To do this,
NIH3T3 (mouse) cells were first transfected with a variety o f fluorescent protein-TR
fusions and then, approximately 24 hours post transfection, a series o f extractions
were performed to remove elements of the cytoskeleton from the cells. For analysis
of intact, whole cells (WC), some samples were fixed immediately. Cytoskeletal
(CSK) extractions used salt and detergents to remove the soluble components of the
cells. This extraction should remove all soluble components o f the cell, and leave the
cytoskeleton undisturbed (Spector et al., 1998). Finally, the Nuclear MatrixIntermediate Filament (NM-IF) extraction used DNase, salts, detergents, and
ammonium sulfate to extract most of the microtubules, actin filaments, DNA, and
residual soluble components o f the cell, leaving the nuclear matrix and the more
stable intermediate filaments undisturbed. If NMIF fractionation is complete, then
the DNA should be digested by DNase and nuclear staining by DAPI should be
absent or barely visible. Two alternative protocols for these in situ fractionations
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were tested. In order to verify that the NM-IF extraction procedure was, in fact,
removing the majority o f microtubules and actin filaments, and that the CSK
procedure was affecting the cytoskeleton to a lesser degree, control experiments were
performed. NIH3T3 cell were transiently transfected with expression vectors for
YFP-actin or YFP-tubulin. Approximately 24 hours post transfection, these cells
were then subjected to the three fixation procedures. Distribution patterns and percent
expression were recorded for each slide (Appendix).
YFP-actin in unfractionated, whole cells (WC) had three main types of
distributions. In some cells, approximately 69%, the YFP-actin was diffuse
throughout the entire cell (Figure 5; Figure 6). In approximately 12% o f cells, the
distribution o f YFP-actin was more punctate, containing aggregates or foci in the
cytoplasm. In approximately 19% of cells, full filaments or stress fibers were visible.
Pilot studies indicated that the distributions changed slightly depending on how long
the cells were incubated after transfection and before fixation. The longer the cells
were incubated, the more cells with visible stress fibers were observed. This is
probably due to more o f the expressed YFP-actin being incorporated into the larger
stress fibers. Thus, for consistency in subsequent experiments, in all slides that were
scored, the cells were fixed 24 hours post transfection.
In WC fixation slides, approximately 13% o f all cells fluoresced indicating
YFP-actin expression, and retention during fixation (Figure 7). This is a low
transfection efficiency, but was consistent among trials. In the CSK fixations, YFPactin was detectible in only 6% o f cells indicating that this extraction removed some
of the actin cytoskeleton. The number o f cells with detectable YFP-actin was reduced

37

la

YFP-actin

2b

YFP-actin

3a

YFP-tubulin

9

Figure 5. Intracellular distribution patterns of Y FP-actin and YFP-tubulin. Normal
WC distribution o f YFP-actin ranges from diffuse ( la), to filament/stress fibers visible (lb ),
to a punctate distribution with cytoplasmic foci (2a.2b). YFP-tubulin distributions are
generally diffuse in the cell, either with a whole cell distribution (3a) or mostly cytoplasmic
(3b).
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6A. YFP-tubulin norm al distribution

% cells

only cytoplasmic

6B. YFP-actin normal distribution

filam ents/stress fibers

diffuse

punctate/foci

Figure 6. Normal distributions of YFP-tubulin and YFP-actin. YFP-tubulin has
normal distributions o f throughout the entire cell in approximately 27% of cells and
only cytoplasmic distribution in approximately 73% of cells (6A). YFP-actin has
normal distributions o f filaments/stress fibers in 19% o f cells, diffuse distribution in
69% o f cells, and punctate/foci distribution in 12% of cells (6B).

39

7 A. YFP-tubulin expression and WC, CSK, NMIF
extractions
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Figure 7. Summary of the effects of WC, CSK, and NMIF extractions on YFPtubulin and YFP-actin. NMIF extraction procedure causes number of cells
expressing YFP-tubulin (7A) and YFP-actin (7B) to decrease due to removal of the
actin and tubulin cytoskeleton in this procedure.
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to 0.8% with the NM-IF fixations, indicating that most of the actin cytoskeleton was
extracted, as expected. On the NMIF slides, DAPI staining o f the nucleus was also
extremely attenuated, indicating effective digestion of DNA during the procedure.
In the CSK and NM-IF fixations, the intracellular distribution pattern of YFPactin also changed somewhat, with more cells having cytoplasmic foci in the NM-IF
samples. However, because the results were highly variable, and sample sizes were
low, the changes in distribution between the WC, CSK, and NM-IF fixations gave
significant p values, but had very low likelihood rations (p<0.0001, LR=0.0006).
YFP-tubulin had only two WC distributions that were easily categorized.
These were diffuse throughout the entire cell, and diffuse but mostly cytoplasmic
(Figure 5). In the WC fixation experiments, approximately 27% of transfected cells
scored showed whole cell distributions, while 73% of cells had mostly cytoplasmic
distributions. This did not change much in CSK fixations or NM-IF fixations. These
results gave significant p values but the actual data were highly variable (p=0.0003,
LR=0.1149), and once again may be skewed due to the low sample size resulting
from very few cells expressing YFP-tubulin in the NM-IF experiments.
In the WC fixations, approximate YFP-tubulin expression and presence was
noted in 40% o f cells (Figure 7). This transfection efficiency was much higher than
for that o f YFP-actin. In CSK fixations this dropped to 11%. In NM-IF fixations,
only 2% o f cells still showed YFP-tubulin expression. This difference was significant
(p<0.0001, LR=0.1695) and demonstrated that the NM-IF fixation did, in fact, extract
most o f the microtubule cytoskeleton as anticipated. Once again, DAPI staining of
the nucleus was greatly reduced, indicating removal of most of the DNA.

Using one protocol (Fey and Penman, 1988), the NM-IF fixations did not
remove most of the microtubules or actin filaments. The most effective fixation
protocol o f this type and the protocol followed for the remainder o f experiments was
adapted from Cells: A Laboratory Manual (Spector et al., 1998).
After the efficiency of the fixation procedures was established, experiments
were performed to investigate the effect of loss of cytoskeletal components on TR
and variants. If the receptors were associating with an element of the cytoskeleton for
the purpose o f nucleocytoplasmic transport, it is possible that removal o f the
cytoskeletal component would result in loss of the receptor during the extraction
procedure, or a change in receptor subcellular localization. If the receptor was not
associated with the cytoskeleton or the nuclear matrix, the receptor would be entirely
removed with the soluble fraction during the CSK extraction.

GFP-G121A distribution shifts to more cytoplasmic upon cytoskeleton disruption
The first receptor studied was GFP-G121 A. G121A is an in vitro generated
transactivation mutant o f TR(3. This receptor has a more cytoplasmic localization
than normal TR. G FP-TRa is almost completely nuclear is its localization pattern
with fluorescence microscopy, although it has been shown to shuttle rapidly between
the cytoplasm and the nucleus (Bunn et al., 2001)(Figure8, panel 1). GFP-TRp is
more varied in its localization pattern, but still has a more nuclear distribution (Figure
8, panel 2). There is a more cytoplasmic localization o f GFP-G121A, and the
distributions of GFP-G121A vary widely cell to cell. Some cells exhibit diffuse
whole cell localization, some have cytoplasmic foci, and some have a perinuclear
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G FP-TRcc
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Figure 8. N orm al distributions o f GFP-TRcc, G F P -T R p ,an d G F P-G 121 A. G FP TRcc has an alm o st entirely n u clear distrib u tio n ( lab ), w hile TR P has a m ore
cytoplasm ic portion ( 2 a b ) . G F P -G 121A has a w ide range o f distrib u tio n s, from
cytoplasm ic foci (3ab), to d iffu se w hole cell ( 4 a b ) , to perinuclear. (5ab)
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distribution (Figure 8, panels 3-5). An entire spectrum o f distributions exists between
these distributions as well. Due to this more cytoplasmic localization of GFP-G121A
compared with TRa and TR|3, it therefore may show the most dramatic change if an
association with the cytoskeleton does exist.
For the purpose o f consistency in tabulating data, a categorization system was
established for all receptors. A ranking o f 0 through 4 was assigned to each cell, and
then grouped according to being a diffuse distribution, or a punctate distribution (see
Materials and Methods) (Figure 9). After all cell counts were made, the results from
each o f these groups were combined into appropriate larger groups, depending on the
receptor studied for the purpose of statistical analysis. In the case o f the WC, CSK,
and NMIF experiments, results for a distribution score of 4 and 3 were grouped
together as “more nuclear”, while scores of 2,1,and 0 were grouped together as “even
(whole cell) or cytoplasmic” distributions. Comparing CSK and NMIF fixations,
there was a significant change in distribution of GFP-G121A (p<0.0001) (Figure 10).
In WC fixations, approximately 58% o f cells exhibited an even/cytoplasmic
distribution, while almost all cells in CSK and NMIF fixations exhibited this
distribution. Also, the percentage o f cells exhibiting a punctate distribution was
approximately 26% for WC fixations. This percentage rose dramatically in CSK and
NMIF fixations with 86% o f cells with punctate distributions of GFP-G121A in CSK
fixations and 92% o f cells with punctate distributions in NMIF fixations (Figure 10).
These data display a significant difference where removal o f the cytoskeleton results
in a more cytoplasmic and more punctate distribution for the localization o f GFPG121A.
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Figure 9. D istribution categories for scoring the su b cellu lar
d istribution pattern o f T R and varian ts. Scoring exam ples for
receptors; all nuclear (4), more nuclear (3), even whole cell (2), more
cytoplasm ic (1), and entirely cytoplasm ic (0). Cell exam ples o f scores 3?
1, and 0 above would also be counted as punctate distributions with foci.
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10A. GFP-G121A distributions in WC, CSK, NMIF extractions

% c e ll s
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□ more nuclear

WC

CSK

NMIF

10B. Percentage of cells with punctate distributions of GFP-G121A
in WC, CSK, NMIF extractions

WC

CSK

NMIF

Figure 10. Effects of WC, CSK, and NMIF extractions on GFP-G121A
distribution. Distribution o f GFP-G121A shifts to more cytoplasmic in CSK and
NMIF extractions (10A). Distribution of GFP-G121A also shifts to more
punctate/foci distribution in CSK and NMIF extractions (10B).
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GFP-TRp localization shifts to more cytoplasmic with cytoskeletal disruption
GFP-TRp exhibited a more nuclear WC distribution (Figure 8, panels 2a-2b).
Approximately 70% of cells had a more nuclear distribution scored as 3 or 4. In
addition, approximately 53% o f cells were scored as having punctate distributions.
These distributions changed dramatically with CSK and NMIF fixations. In CSK
fixation, only 17% o f cells had more nuclear distributions, and in the NMIF fixations,
only 7% (p<0.001, LR=0.4517) (Figure 11). The presence o f punctate distributions
increased as well to close to 100% in both types of fixations (p<0.0001, LR=0.0069)
(Figure 11). Once again, the receptor localization shifted to a more cytoplasmic and
more punctate distribution when the cytoskeleton was removed.

G FP-TRa distribution shifts to more cytoplasmic upon cytoskeletal disruption
As discussed previously, GFP- T R a shuttles between the cytoplasm and the
nucleus, although it displays an almost completely nuclear distribution pattern.
Approximately 99% of cells scored had a more nuclear distribution with a score of 4
or 3 (Figure 8, panel 1). In CSK fixations, this percentage dropped to 58%, and
dropped further to only 39% in NMIF fixations (p<0.0001, LR=0.0988)(Figurel2,
panel 1; Figure 13). Foci distributions changed significantly as well, from only
approximately 15% o f cells with GFP- T R a foci distributions in WC fixations to 54%
and 80% o f cells with foci distributions in CSK and NMIF fixations respectively
(p<0.0001, LR=0.3152)(Figure 13). Once again, the overall shift was towards more
cytoplasmic and more punctate distributions upon removal o f the cytoskeleton.
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11 A. GFP-TRp distributions in WC, CSK, NMIF extractions

%ce lls
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11B. Percentage of cells with punctate/foci distributions of
in WC, CSK, N M I F extractions

G F P -T R p

% c e ll s

CSK

NMIF

Figure 11. Effects of WC, CSK, NMIF extractions on GFP-TRp. Distribution of
GFP-TRp changes to more cytoplasmic (11 A) and more punctate/foci (1 IB) with
CSK and NMIF fixations.

Figure 12. C F P -T R a distributions in NMIF, cytochalasin D, and colchicine
experiments. Distributions change to more cytoplasmic and more foci with
NMIF fixations (1 ).and cytochalasin D experiments for actin disruption (2), and
colchicine experiments for microtubule disruptions (3). Also note with NMIF
fixatin the removal o f chromatin as evident by reduced D A PI nuclear staining
(lb ).
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13A. GFP-TRa distributions with WC, CSK, NMIF extractions

■ more nuclear
□ even/cyto.

13B. Percentage of cells with punctate/foci distributions of
WC, CSK, N M I F extractions
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G F P -T R a
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Figure 13. Distributions of G FP-TRa in WC, CSK, NMIF extractions.
Distributions o f G FP-TRa shift to more cytoplasmic ( 13 A) and more punctate/foci
(13B) with CSK and NMIF extractions.
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In summary, the general shift for GFP-TRa, GFP-TRp, and GFP-G121A was
towards a more cytoplasmic and more punctate distribution upon removal of the
cytoskeleton in NMIF fixations. The CSK fixations resulted in the same shift, but to
a lesser degree, possibly due to some of the cytoskeleton being extracted during
fixation, as indicated through YFP-actin and YFP-tubulin controls. Taken together,
these results indicate that removal o f the actin and microtubules does significantly
effect the location o f the receptor in the cell.

CYTOCHALASIN D ACTIN DISRUPTION MAY AFFECT RECEPTOR
LOCALIZATION
The next set of experiments performed was aimed at selectively disrupting the
actin filament system in living cells to determine the resulting effects on receptor
localization. This procedure is less harsh than the previous extraction procedure. It
involves disrupting a selective element o f the cytoskeleton in live cells, and allowing
time for TR distribution to change accordingly. To do this, the actin disrupting drug
cytochalasin D was used. Cytochalasin D is a fungal alkaloid which works by
binding to the (+) end of the filament and causing disassembly at the (-) end of the
filament. NIH3T3 cells were once again transfected with expression vectors for
fluorescent protein constructs including YFP-actin, YFP-tubulin, GFP-G121 A, GFPTR a, and GFP-TRp. 24 hours post transfection, the cells were treated with
cytochalasin D, fixed , and viewed with fluorescence microscopy to determine
localization patterns. Various concentrations of cytochalasin D were used including
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5pM, lOpM, and 15pM, to determine the most appropriate concentration. 15pM
produced the most dramatic results, without compromising the integrity of the cell.

YFP-actin controls
To assess the efficiency o f actin disruption on the actin cytoskeleton, cells
were transfected with YFP-actin, and then treated with cytochalasin D, vehicle
(DMSO) alone, or no treatment. Upon treatment with cytochalasin D, NIH3T3 cells
should appear more rounded up than their normal spread appearance of NIH3T3 cells,
possibly with some protrusions from the cytoplasm (Ribiero et al., 1997).
Depolymerized actin also may accumulate into foci in the cytoplasm. Since the
majority o f YFP-actin had a diffuse whole cell appearance (Figure 5), YFP-actin
would give a good marker for cell shape and distribution of actin in the cell. There
were no obvious or significant differences in the cells receiving no treatment and the
cells treated with DMSO vehicle. However, there was a significant difference in the
number o f cells with a rounded appearance in the 15pM cytochalasin D treatment
group(p,0.0001, LR=0.1999). A much greater percentage o f cells appeared rounded
after treatment with cytochalasin D (Figure 14).

GFP-G121A, GFP-TRp, and G FP-TRa with cytochalasin D
Having determined the optimal concentration of cytochalasin D, cells were
then transfected with GFP-G121 A, GFP-TRp, or GFP-TRa, and distributions of these
receptors in cells treated with cytochalasin D or vehicle were recorded. Larger
groupings of distribution scores were made, with 4 and 3 being grouped together as
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Vehicle

15 uM cytochalasin D

%

YFP-actin
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30 uM colchicine

YFP-tubulin
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m

Figure 14. The effect of cytochalasin D and colchicine on cell shape. As indicaled by the
distribution pattern o f YFP-actin and YFP-tubulin, cells round upon treatment with either 15
uM cytochalasin D or 30 uM colchicine.
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“more nuclear”, and scores o f 2, 1, and 0 grouped as “even/cytoplasmic” for GFPG121A and GFP-TRp distributions. For GFP-TRa, a score of 4 was considered “all
nuclear”, and scores o f 3 ,2 , 1, and 0 were grouped together as “some cytoplasmic” .
The distributions o f GFP-G121A and GFP-TRa shifted to more cytoplasmic
distributions upon cytochalasin D treatment (Figure 12, panel 2, Appendix). Both p
values indicated significant results(p,0.0001,LR=0.0054; p<0.0001, LR^O.4572
respectively), however, the likelihood ratio for GFP-G121A was poor indicating
variation among trials. G FP-TRa also shifted towards a significantly more punctate
distribution upon cytochalasin D treatment as well. The results for GFP-TRp showed
no significant change in distribution o f the receptor between vehicle and cytochalasin
D experiments (p0.8738, LR=0.0068).
In summary, results suggest the very interesting possibility that there is an
interaction between the actin cytoskeleton and TR a, but not TRp. However, more
experiments will be required to unequivocally show this interaction.

DISRUPTION OF MICROTUBULES LEADS TO CHANGES IN RECEPTOR
LOCALIZATION

The microtubule disrupting drug colchicine was used in the next set of
experiments to determine the individual role that microtubules may play in the
nucleocytoplasmic shuttling o f TR. Colchicine is derived from a plant and causes
stabilization o f microtubules at low concentrations and depolymerization of
microtubules at high concentrations through inhibition of microtubule dynamics
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(Lodish et al., 1995). In this case, 30jaM of colchicine was used, according to
established procedures (Hollingshead, 2001).

YFP-tubulin controls
To determine the efficiency of colchicine in disrupting the microtubule
network, experiments were performed using YFP-tubulin. If microtubules were being
disrupted, rounding up o f the cells with cytoplasmic blebs protruding from the
membrane should occur. There were no significant differences in the shape of cells
treated with vehicle, and cells with no treatments at all. There was a significant
difference between vehicle treated and colchicine treated cells, with colchicine treated
slides having a greater percentage of cells with a rounded appearance (Figure 14).
This is evidence that the microtubule disruption with colchicine is effective.

GFP-G121A, GFP-TRp, and G FP-TRa distributions change with colchicine
disruption o f microtubules

For colchicine disruption experiments, receptor localizations were once again
grouped into larger categories. These categories were the same as those for the
cytochalasin D experiments. In the case of all receptors, distributions changed
significantly to more cytoplasmic distributions with colchicine treatments (Figure 15;
Appendix). G FP-TRa also shifted towards a more punctate distribution with
colchicine treatment (Figure 12, panel 3). GFP-TRp shifted to a less punctate
distribution, and no significant changes in foci were observed for GFP-G121 A. In
summary, the results o f the microtubule disruption data indicate a more dramatic
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15. Effects of colchicine on recep to r localization

■ GFP-TRa

% cells
cytoplasmic

□ GFP-TRb
□ GFP-G121A

vehicle

colchicine

Figure 15. Effects of colchicine on receptor localization. G FP-TR a shifts to more
cytoplasmic localization (scores 3-0) upon colchicine treatment. GFP-TRp and GFPG121A also shift to more cytoplasmic localizations (scores 2-0) upon colchicine
treatments.
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change in distributions o f the receptors when microtubules are disrupted than when
actin fdaments are disrupted. Since there was a shift to a more cytoplasmic
distribution, this suggests a possible role for intact microtubules in nuclear import.

ADDITIONAL DRUG TREATMENT CONTROLS
In light o f the data obtained from cytochalasin D and colchicine experiments,
it became clear that it was necessary to test the specificity o f the respective disrupting
agents for the different elements o f the cytoskeleton. Due to the close association of
actin and microtubules (Yarm et al, 2001), it was possible that cytochalasin D was
indirectly causing disruption o f the microtubule cytoskeleton, and colchicine was
indirectly effecting the actin cytoskeleton.
The YFP-tubulin gene template was transfected into cells which were then
treated with vehicle or cytochalasin D to assess whether the drug disrupted the
microtubules. The two distribution categories for YFP-tubulin, whole cell
distribution and mostly cytoplasmic distribution, were used to classify localization.
There was a difference in distribution between vehicle and cytochalasin D treated
cells; in drug treated cells YFP-tubulin shifted to more cytoplasmic
distribution;however the likelihood ratio was poor (Appendix).
Next, YFP-actin was transfected into cells which were then treated with
colchicine or vehicle to determine if colchicine indirectly affected the actin
cytoskeleton. Once again, the normal YFP-actin distributions were used as the
classification categories. There was essentially no difference in distributions between
vehicle and colchicine treated cells (Appendix).
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These results show that microtubule disruption via colchicine has little to no
effect on the actin cytoskeleton, and therefore indicate that the results obtained from
the colchicine disruption experiments are truly due to the disruption of the
microtubules. On the other hand, cyochalasin D may affect microtubules to a certain
degree, not just the actin cytoskeleton. This may mean that some part of the actin
disruption data could actually be due to a disruption of the microtubule cytoskeleton
as well.

EVIDENCE FOR COLOCALIZATION OF GFP-G121A WITH ACTIN AND
MICROTUBULES
Studies were also performed to assess whether G121A colocalizes with either
the actin filaments or the microtubules. G121A was used due to its more cytoplasmic
localization, which would make it easier to visualize colocalization with elements of
the cytoplasm. To do this, CFP-G121A was cotransfected with either YFP-tubulin or
YFP-actin.
Interestingly, in some cells CFP-G121A colocalized with YFP-tubulin and
YFP-actin (Figure 16). In general, approximately 50% showed some degree of
colocalization o f G121A with either actin or tubulin. In some cells, the colocalization
was almost complete, however, in others, there was no colocalization. Results were
not quantified due to the extremely variable results. The variability o f results may be
due to the cotransfection procedure, and the difficulty o f finding cells with both
proteins expressed at nearly the same levels. Clarification of these observations will
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YFP-actin

YFP-tubulin

C FP-G 121A

C F P -G 12IA

overlay

overlay

Figure 16. Colocalization o f C F P -G 121A and YFP-actin or YFPtubuliin. E x am p les o f n ear 100% co lo calizatio n o f C F P -G 1 2 1 A and Y FPactin o r Y F P -tu b u lin . T h is d istrib u tio n s rep resen ts only a p ortion o f cells
e x p ressin g both Y F P and C F P co nstructs.
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involve further experimentation, and possibly the use of antibody stains for the
cytoskeleton.

HETEROKARYON EXPERIMENTS INDICATE INTACT M ICROTUBULES
NEEDED FOR SHUTTLING TO OCCUR
The above described experiments showed a more cytoplasmic distribution of
TR when the cytoskeleton was disrupted suggesting that nuclear import may require
an intact cytoskeleton. Thus, the next set of experiments performed were
heterokaryon experiments, a classic method for the analysis o f nucleocytoplasmic
shuttling (Spector et al., 1998). This set o f experiments was aimed at determining
whether shuttling o f T R a was attenuated if an element of the cytoskeleton was
disrupted. This would infer a reliance on this cytoskeletal element for shuttling of the
receptor through the cytoplasm to the NPC. These experiments involved fusing GFPT R a transfected NIH3T3 (mouse) cells with HeLa (human) cells, to determine if
shuttling of G FP-TRa occurs between the nuclei, in the common cytoplasm. GFPT R a was used because it has a mostly nuclear distribution, although it does shuttle
rapidly between the cytoplasm and nucleus, thus allowing for easier determination of
nuclear presence. Heterokaryon slides were treated with vehicle, colchicine, or
cytochalasin D. If shuttling o f the receptor occurs, the receptor should be exported
from the mouse nuclei, and move through the shared cytoplasm to the human nuclei.
In cells in which it could be determined through Nomarski optics that the
NIH3T3 and HeLa cells had fused due to the presence of a continuous cytoplasmic
membrane, localization of the receptor was classified as not shuttling, even shuttling,
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or uneven shuttling where the receptor localization was significantly brighter in the
NIH3T3 nucleus than in the HeLa nucleus. In vehicle treated slides, all
heterokaryons observed had shuttling of the receptor to a certain extent.
Approximately 74% o f heterokaryons had uneven shuttling, while about 26% had
even shuttling.

In cytochalasin D treated slides, once again, all heterokaryons

observed had some degree of shuttling. In colchicine treated slides however, 17 out
o f 22 heterokaryons observed had no shuttling, and 5 heterokaryons had uneven
shuttling (Figure 17). This suggests that when the microtubules are disrupted, GFPT R a can no longer efficiently shuttle between the cytoplasm and nucleus. These
findings point to the intriguing possibility that the microtubules are important for
transport o f TR a.
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Figure 17. Heterokaryons treated with colchicine. In heterokaryons( la,b,c) and
homokaryons (2a,b.,c) treated with colchicine,shuttling of GFP-TRa does not occur between
transfected mouse and untransfected human nuclei. Normal shuttling is observed in
heterokaryons treated with vehicle only (3a.b,c). Nomarski optics show the continuous
cytoplasmic membrane around the nuclei to verify fusion has occured between cells. Nuclei
were stained with Hoechst to distinguish mouse and human nuclei.
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DISCUSSION
TR is an important nuclear receptor which regulates the effects o f the thyroid
hormone in vertebrates. Because the thyroid hormone itself is involved in so many
facets o f development and homeostasis, TR and its function and activity are important
areas o f research. Even though TR exerts its functions in the nucleus, it is possible
that an important step in regulation arises from the receptor’s cytoplasmic behavior.
Since TR is synthesized in the cytoplasm, it must be targeted to, and enter the nucleus
to perform its functions. Investigation into possible associations o f the receptor with
elements of the cytoskeleton is a step in understanding this cytoplasmic behavior.
Evidence presented in this thesis suggests a possible role of the microtubules in
directed transport o f TR from the cytoplasm to the nucleus.

IMPORTANCE OF MICROTUBULES IN TR SHUTTLING
The results in this thesis provide evidence of dramatic changes in distributions
of the receptors that were observed upon microtubule disruption. These results
indicated changes in localizations for all receptors tested, T R a, TRp, and the
transactivation mutant G121A. The significance of microtubule disruption on
receptor localization was confirmed again upon realization that microtubule
disruption had no effect on the actin cytoskeleton, but the results o f the actin
disruption experiments may in fact be an artifact of partial microtubule disruption.
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The results contained in this thesis provide somewhat inconclusive results as to the
possibility o f interaction of forms o f the thyroid hormone receptor with the actin
cytoskeleton. Colocalization studies suggest some degree o f colocalization of actin
and G121A in some cells, although many cells did not exhibit this pattern. Also,
G FP-TR a and GFP-G121A had localization changes when the actin cytoskeleton was
disrupted. Colocalization studies also indicated some degree o f colocalization
between microtubules and G121 A, although the results of these experiments were no
more conclusive than those for actin colocalization. In situ fractionation experiments
also indicated a dramatic change in localization of all three receptors upon extraction
o f the cytoskeleton, although in these experiments no distinction could be made
between actin and microtubules.
If microtubules are in fact important for directed motion of TR through the
cytoplasm, disruption o f the microtubules should lead to slower /less efficient
movement o f the receptor. In this scenario, the kinetics of TR nuclear export would
not be effected, but entry back into the nucleus would be slowed, or completely
blocked. This would result in a cytoplasmic accumulation o f newly synthesized TR
and TR exported from the nucleus upon disruption of its locomotion machinery, the
microtubules. This proposed shift was, in fact observed upon microtubule disruption.
G121A was expected to yield the most interesting results due to its more cytoplasmic
localization. It was believed that observation o f interaction with elements of the
cytoskeleton would be more apparent due to its localization. As it turned out, T R a
proved to have the most dramatic and interesting results due to its primarily nuclear
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localization in normal cells. The shift towards the cytoplasm was more apparent and
striking upon microtubule disruption.
Perhaps the most intriguing data came from the heterokaryon experiments, in
which it was apparent that cytoplasmic movement of T R a was hindered upon
microtubule disruption. This confirms the data suggesting an association between
microtubules and TR, and provides additional evidence towards a locomotive role of
the cytoskeleton for TR. This association would not be unexpected, since many other
nuclear receptors have been shown to utilize the cytoskeleton for movement from the
cytoplasm to the nucleus (Galigniana et al., 1998; Galigniana et al., 1999; Galigniana
et al., 2001;Barsoney et al., 1997, Kamimura et al., 1995).

SIGNIFICANCE OF PUNCTATE DISTRIBUTIONS
The significance o f the punctate distributions of TR and variants observed in
many experiments is somewhat mysterious. The general trend upon cytoskeletal
disruption or removal was towards a more punctate distribution, with foci/aggregates
in the cytoplasm, but there were exceptions. Aggregate formation has been observed
in tubulin and actin upon cytoskeletal disruption as well, and appears unrelated to the
presence o f fluorescent protein fusions (Johnston et al., 1998). This may mean that if
TR is in fact associating with an element of the cytoskeleton, namely the
microtubules, it may be carried into these cytoplasmic foci by the microtubules.
There is also intriguing research into cytoplasmic formations called
aggresomes. These structures appear as accumulations o f aggregated protein
throughout the cytoplasm, which gradually over time progress to a few bright foci at
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the site o f the MTOCs (Garcia-Mata et ah, 2002; Shimohata et al., 2002; Ma and
Lindquist, 2001; Garcia-Mata et al., 1999). It is believed that aggresomes form due to
overexpression o f protein, or misfolded proteins. More specifically, they form when
the existing pathway for protein degradation is overloaded (Johnston et al., 1998).
Transport of aggregated protein occurs via microtubules and the retrograde motor
protein dynein to cause accumulation at the MTOCs (Johnston et al., 1998). Upon
disruption o f the microtubules, it has been shown that aggresomes disperse into
smaller aggregations throughout the cytoplasm, or become perinuclear in distribution
(Shimohata et al., 2002; Johnston et al., 1998).
It is possible that the forms of TR studied are forming aggresomes in some
cells. There has been shown to be a cage of vimentin, which is a protein that makes
up intermediate filaments, surrounding aggresomes in the cytoplasm (Johnston et
al.,1998; Shimohata et al., 2002; Garcia-Mata et al., 2002). If the foci seen for TR are
in fact aggresomes, this may explain the observation that vimentin colocalizes with
G121A in some instances (Hollingshead , 2001). Colocalization with vimentin
occured where G121A had accumulated in foci or aggregates. The colocalization
observed could be due to the formation of aggresomes. It is also possible that this
colocalization was an artifact due to the close association of microtubules and
intermediate filaments, and may only indicate a colocalization with the microtubules.
As discussed earlier, there are no known motor proteins for intermediate filaments, so
an association o f TR with intermediate filaments for the purpose of locomotion within
the cell would be unlikely. It is more likely that the association is due to aggresome
formation, or close association o f vimentin and TR with microtubules.
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If aggresomes are forming, it is unclear as to why this phenomenon is
occurring. It has been demonstrated for other proteins that the GFP tag is not
responsible for aggregation o f proteins (Johnston et al., 1998). It is possible that
since G121A is a mutated form o f TR(3, the protein’s ability to fold correctly is
somewhat hindered, and more o f the protein is sent for degradation and to form
aggresomes. It does appear that a greater percentage of G121A accumulates in foci
or aggregates compared with either TRa or TRp. Misfolding o f G121A is considered
a somewhat unlikely explaination, however, since prior experiments have shown
normal functioning o f G121A with respect to DNA binding and hormone binding
(Nelson et al., 1993). If misfolding was occurring, it seems that these functions
should be hindered as well. A possibility does exist that the receptors are simply
being extremely overexpressed in the experiments presented in this thesis, and this
overexpression is resulting in recruitment of excess TR to aggresomes. Since G121A
has a more cytoplasmic distribution in general, more of the overexpressed receptor
would be available for aggregation than, for example, TRa which is almost entirely
nuclear.
To determine the nature o f foci and aggregates of TR, many other experiments
would have to be performed. It would be helpful to observe live cells with a confocal
microscope over a period o f time. This would allow one to visualize a progression
from many cytoplasmic foci to large aggresomes at the site o f the MTOCs. If this
progression was confirmed, microtubule disrupting drugs would be used to determine
if they caused disruption and dispersal of the large aggresomes into smaller more
dispersed aggregates. Additional studies using vimentin-specific antibodies should
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also be employed to see if the characteristic vimentin cage can by visualized
surrounding the putative TR aggresome. All of these experiments would help to
determine if the aggregates o f TR are in fact aggresomes.

FUTURE EXPERIMENTS
A variety of experiments could be performed to verify the results obtained in
this thesis and to determine if TRs are in fact associating directly with the
microtubules for the purpose o f transport through the cytoplasm. One such
experiment is to clarify the colocalization patterns with actin, microtubules, and
intermediate filaments by using antibody staining of the cytoskeletal filaments, along
with very specific scoring categories. Visualization of the cytoskeleton in this
manner may provide a clearer view o f the actual filament systems than with
transfection experiments, due to the problem o f inefficient incorporation o f the YFPactin and YFP-tubulin into the filament networks inherent in the transfection method.
Another set o f experiments could involve visualization o f receptor movement
in live cells. An advantage o f the transfection methods with fluorescent protein
constructs used in this thesis is that the data provide the groundwork for work on live
cells, since antibody staining can not be used for live cell imaging. In live cells, it
may be possible to compare the rate o f cytoplasmic accumulation o f TR upon
cytoskeletal disruption to the normal accumulation in intact cells. It is also possible
to use fluorescence recovery after photobleaching (FRAP) to photobleach the nucleus
o f cells transfected with G FP-TRa or GFP-TRp. This would allow for observation of
the rate of return of fluorescence to the nucleus over time in normal and cytoskeletal
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disrupted cells. Experiments using heterokaryons and homokaryons could also be
developed in a similar manner.
Additionally, it may be possible to biochemically assess the interaction
between microtubules and TR. Microtubules can be induced to polymerize in vitro
using Taxol. Microtubules could be incubated with combinations of TR, importins,
cell lysates, and other proteins, and then the microtubule fractions of the mixture
analyzed through SDS-PAGE and Western blotting. This would allow investigation
as to whether TR does biochemically interact with the microtubules, and if so, what
other factors are necessary for the interaction. This type of experiment may be
difficult, due to the uncertainty o f what factors may bridge the interaction o f TR with
the microtubules.

CONCLUSIONS
The role o f the cytoskeleton in the cytoplasmic shuttling of TR has not been
investigated until now. Since so many other individual proteins related to TR have
been shown to rely on the cytoskeleton for transport in the cytoplasm, it seems
plausible that TR would utilize a similar mechanism. Examples o f proteins utilizing a
similar mechanism are the glucocorticoid receptor, the vitamin D receptor, and
parathyroid hormone related protein (Galigniana et al., 1998; Galigniana et al., 1999;
Galigniana et al., 2001; Barsony et al., 1997, Kamimura et al., 1995; Lam et al.,
2002). All o f these proteins rely specifically on the microtubules for directed
transport through the cytoplasm. The results of this thesis suggest a possible role for
microtubules in movement of TR through the cytoplasm to the nucleus, while actin
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does not appear to be involved in transport. Association with microtubules may
prove to be another step involved in the regulation of TR nuclear import and
subsequent regulation o f T3 responsive genes which had yet to be identified. Since
the thyroid hormone and its receptor affect so many processes in vertebrates, any
information on the functioning o f TR helps us to understand the processes which TR
controls. Elucidation o f the functions o f TR may lead to more understanding of how
mutant forms o f TR cause disease in humans, and possibly lead to better treatments
for these diseases in the future.
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p=0.0003, L R =0.1149

Y FP -actin W C /C S K /N M

WC
CSK
NMIF

fil
23
0
0

63
0
9

14
0
26

total cells # exp
224
100
219

32
4
1

WC
CSK
NMIF

24
75
7

70
11
17

6
14
19

211
201
206

26
5
2

WC
CSK
NMIF

9
2
5

75
14
21

16
84
74

100
100
100

14
10
1

p<0.0001 ,LR =0.0006

diff

foci

p<0.0001, LR =0.3145

72

A C TIN D IS R U P TIO N E XP E R IM E N TS
Y FP -actin c y t o - D __________

rounded
norm
DMSO
15uM CD

YFP -tubu lin cyto-D

spread

87
47
172

DMSO
15uM CD

211
67
73

norm
DMSO
15uM CD

30
47
187

42
76
64

norm
DMSO
15uM CD

43
43
124

67
57
25

n o rm /D M S O :p =0.1072L R = 0.1934
DMSO/CD:p<O.OOQ1 ,L R =0.1999

whole cell mostly cyto
48
52
57
45

DMSO
15uM CD

74
42

26
58

DMSO
15 uM CD

77
46

24
59

DMSO
15uM CD

86
45

20
68

p <0.0001,LR =0.0003

G FP -TR a cyto-D

diff

foci

all nuc.(4) some cyt(3,2,1,0)
69
31
98
19
62
45

norm
DMSO
15 uM CD

92
102
72

18
15
30

norm
DMSO
15 uM CD

75
40
53

30
15
49

74
38
53

31
17
49

norm
DMSO
15 uM CD

36
84
67

11
21
35

36
83
57

11
22
45

p<0.0001, LR =0.8132

p<0.0001, LR =0.4572

G F P -T R b cyto-D

diff

foci

some nuc(4,3)
28
48
40

even/cyt.(2,1,0)
34
81
36

norm
DMSO
15 uM CD

21
27
8

41
102
68

norm
DMSO
15uM CD

3
20

78
90

18
22

63
88

norm
DMSO
15uM CD

3
10

48
70

18
14

33
66

p=0.3141, LR =0.0006

p<0.8738, LR=0.0068

G F P -G 121A cyto-D

DMSO
15uM CD

more nuc (4,3)
100
18

even/cyt(2,1,0)
117
200

DMSO
15uMCD

52
30

49
73

DMSO
15uM CD

55
17

61
106

p<0.0001, LR =0.0054
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M IC R O T U B U L E D IS R U PTIO N E XP E R IM E N TS
Y F P -tu b u lin co lch icin e

Y FP -actin colchicine

diffuse

filaments

spread

rounded
normal
DMSO
30uM colc

16
14
84

84
86
16

normal
DMSO
30uM colc

8
22
86

92
78
14

normal
DMSO
30uM colc

25
24
90

75
76
10

foci

DMSO
30uM colc

9
8

85
84

6
8

DMSO
30uM colc

7
9

89
89

4
2

DMSO
30uM colc

12
7

83
90

5
3

p=0.7709, LR=0.5781

norm /D M S O : p=0.2416, LR=0.0341
D M S O /C olch: p <0.0001,L R =0.7630
G FP -Tra co lch icin e

DMSO
30uM colc

all nuc(4) some cyto (3,2,1,0)
83
17
65
35

Diffuse

Foci
83
64

17
36

DMSO
30uMcolc

82
54

18
46

84
61

16
39

DMSO
30uM colc

78
62

22
38

81
64

19
36

p<0.0001, LR =0.4329

p<0.0001, LR =0.7752

G F P -T R b colchicine

DMSO
30uM colc

more nuc (4,3)
59
26

even/cyt. (2,1,0)
41
74

diffuse

foci
43
65

57
35

DMSO
30uM colc

58
30

42
70

46
61

54
39

DMSO
30uM colc

49
33

51
67

48
59

52
41

p<0.0001 ,L R = 0.1977
G FP -G 121a

DMSO
30uM colc

more nuc (4,3)
61
5

p<0.0001, LR =0.5247

even/cyto(2,1,0)
48
95

DMSO
30uM colc

49
16

51
84

DMSO
30uM colc

48
11

52
89

p<0.0001, LR =0.0200

H E T E R O K A R Y O N EXPE R IM EN TS

w ith co lch icin e

DMSO
colc

shuttling (even)
6
0

shuttling (uneven)
14
5

not shuttling
0
17

shuttling (uneven)
15
17

not shuttling
0
0

w ith cyto ch alasin D

DMSO
Cyto-D

shuttling (even)
5
4

76
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